Filter posts

Flu Study Finds Only One H1N1 Vaccine Shot Needed

Early results from clinical trials show that the majority of healthy adults may only need …

Team at BrainCells using brain cells

An interview with James A. Schoeneck, Chief Executive Officer, BrainCells, Inc.: Can you describe the …

Anadys Pharmaceuticals Begins Phase II Study Dosing of ANA598

Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) announced today that dosing has begun in a Phase II …

XOMA Collaboration with Arana Therapeutics

XOMA Ltd. (Nasdaq:XOMA) and Arana Therapeutics Limited, a wholly-owned subsidiary of Cephalon, Inc. (Nasdaq:CEPH) will …

PTC Therapeutics Announces Phase III Trial of Ataluren

PTC Therapeutics, Inc. (PTC) initiated a Phase III trial of ataluren, an investigational protein restoration …

The latest from Trubion Pharmaceuticals

An interview with Dr. Peter A. Thompson, MD, FACP, President, CEO, & Chairman of the …

Forbes on Flu

Forbes’ Jonathan Fahey wrote an excellent article on influenza and the H1N1 virus this morning. …

Trubion Collaboration with Facet Biotech

Trubion Pharmaceuticals, Inc. (Nasdaq: TRBN) and Facet Biotech Corporation (Nasdaq: FACT) recently announced an agreement …

Complete Genomics Sequences 14 Human Genomes

Complete Genomics Inc. announced that 14 human genomes now have been sequenced, analyzed and delivered …

Race to Develop H1N1 Vaccine

Execs from Inovio Biomedical Corporation and Novavax will be speaking at BIF about their experience …